These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 26265659)

  • 1. Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study.
    Deftereos S; Giannopoulos G; Angelidis C; Alexopoulos N; Filippatos G; Papoutsidakis N; Sianos G; Goudevenos J; Alexopoulos D; Pyrgakis V; Cleman MW; Manolis AS; Tousoulis D; Lekakis J
    Circulation; 2015 Oct; 132(15):1395-403. PubMed ID: 26265659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction.
    Mewton N; Roubille F; Bresson D; Prieur C; Bouleti C; Bochaton T; Ivanes F; Dubreuil O; Biere L; Hayek A; Derimay F; Akodad M; Alos B; Haider L; El Jonhy N; Daw R; De Bourguignon C; Dhelens C; Finet G; Bonnefoy-Cudraz E; Bidaux G; Boutitie F; Maucort-Boulch D; Croisille P; Rioufol G; Prunier F; Angoulvant D
    Circulation; 2021 Sep; 144(11):859-869. PubMed ID: 34420373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance.
    Di Chiara A; Dall'Armellina E; Badano LP; Meduri S; Pezzutto N; Fioretti PM
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):587-92. PubMed ID: 20588136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial.
    Gwag HB; Kim EK; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Lee SH; Chang SA; Park SJ; Lee SC; Park SW; Jang WJ; Lee M; Chun WJ; Oh JH; Park YH; Choe YH; Gwon HC; Hahn JY
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]).
    Pasupathy S; Tavella R; Grover S; Raman B; Procter NEK; Du YT; Mahadavan G; Stafford I; Heresztyn T; Holmes A; Zeitz C; Arstall M; Selvanayagam J; Horowitz JD; Beltrame JF
    Circulation; 2017 Sep; 136(10):894-903. PubMed ID: 28634219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.
    Lincoff AM; Roe M; Aylward P; Galla J; Rynkiewicz A; Guetta V; Zelizko M; Kleiman N; White H; McErlean E; Erlinge D; Laine M; Dos Santos Ferreira JM; Goodman S; Mehta S; Atar D; Suryapranata H; Jensen SE; Forster T; Fernandez-Ortiz A; Schoors D; Radke P; Belli G; Brennan D; Bell G; Krucoff M;
    Eur Heart J; 2014 Oct; 35(37):2516-23. PubMed ID: 24796339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia.
    Lønborg J; Kelbæk H; Vejlstrup N; Bøtker HE; Kim WY; Holmvang L; Jørgensen E; Helqvist S; Saunamäki K; Terkelsen CJ; Schoos MM; Køber L; Clemmensen P; Treiman M; Engstrøm T
    Circ Cardiovasc Interv; 2012 Apr; 5(2):288-95. PubMed ID: 22496084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of necrosis markers and cardiovascular magnetic resonance-derived microvascular perfusion in reperfused ST-elevation myocardial infarction.
    Husser O; Bodi V; Sanchis J; Nunez J; Mainar L; Rumiz E; Lopez-Lereu MP; Monmeneu JV; Forteza MJ; Oltra R; Riegger GA; Chorro FJ; Llacer A
    Thromb Res; 2009 Nov; 124(5):592-600. PubMed ID: 19540571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction.
    Sörensson P; Saleh N; Bouvier F; Böhm F; Settergren M; Caidahl K; Tornvall P; Arheden H; Rydén L; Pernow J
    Heart; 2010 Nov; 96(21):1710-5. PubMed ID: 20956486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial).
    Daaboul Y; Korjian S; Weaver WD; Kloner RA; Giugliano RP; Carr J; Neal BJ; Chi G; Cochet M; Goodell L; Michalak N; Rusowicz-Orazem L; Alkathery T; Allaham H; Routray S; Szlosek D; Jain P; Gibson CM
    Am J Cardiol; 2016 Sep; 118(5):625-31. PubMed ID: 27392509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of colchicine to reduce perioperative myocardial damage in patients who underwent on-pump coronary artery bypass grafting.
    Giannopoulos G; Angelidis C; Kouritas VK; Dedeilias P; Filippatos G; Cleman MW; Panagopoulou V; Siasos G; Tousoulis D; Lekakis J; Deftereos S
    Am J Cardiol; 2015 May; 115(10):1376-81. PubMed ID: 25784519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol - The COVERT-MI Study.
    Bresson D; Roubille F; Prieur C; Biere L; Ivanes F; Bouleti C; Dubreuil O; Rioufol G; Boutitie F; Sideris G; Elbaz M; Bochaton T; De Bourguignon C; El Jonhy N; Dufay N; Dhelens C; Croisille P; Prunier F; Angoulvant D; Ovize M; Maucort-Boulch D; Mewton N
    Cardiology; 2021; 146(2):151-160. PubMed ID: 33582664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
    Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
    J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction.
    Chen WR; Chen YD; Tian F; Yang N; Cheng LQ; Hu SY; Wang J; Yang JJ; Wang SF; Gu XF
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial.
    Mahaffey KW; Granger CB; Nicolau JC; Ruzyllo W; Weaver WD; Theroux P; Hochman JS; Filloon TG; Mojcik CF; Todaro TG; Armstrong PW;
    Circulation; 2003 Sep; 108(10):1176-83. PubMed ID: 12925455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
    Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.